Osteoarthritis is a wear-and-tear condition where joint cartilage breaks down over time, while rheumatoid arthritis is an autoimmune disease where the immune system attacks the joints. Osteoarthritis is roughly three times more common, affecting about 12% of U.S. adults compared to about 4% for rheumatoid arthritis. Despite both causing joint pain and stiffness, they differ in their causes, the joints they target, how they feel day to day, and how they’re treated.
What Causes Each Condition
Osteoarthritis begins with mechanical damage. Over years of use, the cartilage that cushions your joints wears thin, and the underlying bone changes shape in response. Age, obesity, previous joint injuries, and repetitive physical stress all accelerate this process. It’s fundamentally a problem of structure: the joint physically deteriorates.
Rheumatoid arthritis starts with the immune system. In people with a genetic predisposition, environmental triggers like cigarette smoke can cause the immune system to misidentify normal joint proteins as threats. White blood cells flood the joint lining, creating chronic inflammation that erodes cartilage and bone from the inside. The joint destruction in RA is driven by immune activity, not mechanical wear.
Which Joints Are Affected
Osteoarthritis tends to hit the joints that bear the most weight or get the most use: knees, hips, the lower spine, and the base of the thumb. In the hands, it often shows up at the fingertips and middle finger joints, sometimes producing small bony bumps called Heberden’s nodes (at the fingertip joint) or Bouchard’s nodes (at the middle joint). These pea-sized growths are a hallmark of OA and don’t appear in rheumatoid arthritis.
Rheumatoid arthritis typically starts in the small joints of the hands and feet, particularly the knuckles and the ball of the foot. About half of RA patients develop foot problems within three years of diagnosis, with forefoot deformities progressing quickly. RA has long been described as “symmetrical,” meaning it affects the same joints on both sides of the body. But researchers have questioned this idea. A 2010 revision of RA classification criteria actually dropped symmetry as a diagnostic requirement, because relying on it could lead to missed diagnoses when the pattern doesn’t hold.
How They Feel Different Day to Day
Morning stiffness is one of the most practical ways to tell the two apart. With osteoarthritis, stiffness after waking typically loosens up within 30 minutes to an hour. With rheumatoid arthritis, morning stiffness usually lasts longer than an hour and can persist well into the day.
OA pain tends to worsen with activity and improve with rest. If you’ve been on your feet all day, your knees ache more by evening. RA pain behaves differently: it can flare unpredictably and often feels worse after periods of inactivity, not just at the end of a long day.
Because rheumatoid arthritis is a systemic disease, it also causes symptoms that have nothing to do with joints. Fatigue, low-grade fever, and a general feeling of being unwell are common, especially during flares. Anemia is one of the most frequent non-joint symptoms, and it tends to track with how active the disease is. Over time, RA can involve the lungs, eyes, heart, skin, and nervous system. Dry eyes and dry mouth (from a related condition called Sjögren’s syndrome) show up in 6 to 10% of patients, often early in the disease. Osteoarthritis, by contrast, stays in the joints. You won’t get a fever or fatigue from it.
How Each Is Diagnosed
Osteoarthritis is usually diagnosed based on symptoms, a physical exam, and imaging. X-rays show the classic signs: narrowed joint space where cartilage has worn away, bone spurs (osteophytes) at the joint edges, and thickened bone beneath the cartilage surface. No blood test confirms OA.
Rheumatoid arthritis diagnosis relies on a combination of blood work, imaging, and clinical signs. Two key blood tests look for immune markers. Rheumatoid factor (RF) is present in many RA patients but also shows up in some people without the disease, giving it a specificity of about 85%. The anti-CCP antibody test is more precise, with specificity around 95 to 96%, meaning a positive result is a strong signal. However, the sensitivity of anti-CCP ranges from 53 to 71%, so a negative result doesn’t rule RA out. On X-rays and MRI, RA shows a different pattern than OA: erosions at the margins of the joint rather than bone spurs, and soft tissue swelling from the inflamed joint lining.
Risk Factors That Set Them Apart
Both conditions are more common in women and become more likely with age, but the specific risk profiles diverge from there.
For osteoarthritis, the biggest modifiable risk factor is body weight. Obesity puts extra mechanical load on weight-bearing joints and accelerates cartilage breakdown. Prior joint injuries, especially from sports, are another major contributor. A torn knee ligament at 25 can set the stage for OA at 50.
For rheumatoid arthritis, genetics play a larger role. Family history is one of the strongest predictors, with specific immune system genes (particularly a variant called the shared epitope) significantly raising risk. Smoking is the most important environmental trigger. In people who carry the genetic risk, smoking dramatically increases the chance of developing RA, even at relatively low levels of lifetime exposure. Obesity raises the risk of both conditions, and smoking increases the incidence of both in women, but the genetic and immune-driven nature of RA makes its risk profile distinct.
How Treatment Differs
The treatment goals for these two diseases are fundamentally different. With osteoarthritis, the focus is on managing symptoms: reducing pain, maintaining mobility, and slowing further joint damage through weight management, physical therapy, and anti-inflammatory medications. There is no drug that reverses or halts OA’s progression. When a joint is severely damaged, replacement surgery becomes an option.
Rheumatoid arthritis treatment aims to suppress the immune attack itself, not just relieve symptoms. The cornerstone is a class of drugs called disease-modifying agents (DMARDs), with methotrexate being the most common first choice. These medications don’t just reduce pain; they slow or stop the joint destruction that RA causes. Anti-inflammatory drugs help with day-to-day symptoms, but as Johns Hopkins Arthritis Center notes, they do not change the course of the disease or prevent joint damage on their own. That’s why early, aggressive treatment with disease-modifying therapy is standard for RA. The goal is remission, or as close to it as possible.
This difference in treatment reflects the core distinction between the two diseases. Osteoarthritis is a structural problem you manage over time. Rheumatoid arthritis is an immune system problem you actively fight to control, ideally before significant joint damage occurs.